| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 1372576 | Bioorganic & Medicinal Chemistry Letters | 2011 | 5 Pages |
Multidrug resistance in tumor cells poses a major obstacle to efficient chemotherapy. Several types of agents have been recognized as multidrug resistance inhibitors, among which the tetrahydroisoquinolines is the most studied. In current study 16 furoxan-based nitric oxide-releasing derivatives of tetrahydroisoquinoline were synthesized. Their cytotoxic activities and effects in reversing multidrug resistance have been evaluated. The results revealed that these compounds had moderate cytotoxic effects. Compounds 7a–f, 7h, and 7l showed higher cytotoxicities than the rest, but lower than adriamycin on K562 cell line. Compounds 7d, 7f, and 7l exhibited potent MDR reversal activities on K562/A02 cell line. The accumulation assay indicated that compounds 7d, 7f, and 7l significantly increased the intracellular accumulation of rhodamine123 in K562/A02 cells. Furthermore, these three compounds produced high concentrations of NO in K562/A02 cells. Potentially, the high concentrations of NO produced by NO donor moieties will lead to an increased cytotoxicity to K562/A02 cells. Our results suggested that compounds 7d, 7f, and 7l had anticancer effects, as well as multidrug resistance reversal effects.
Graphical abstractSixteen furoxan-based nitric oxide-releasing derivatives of tetrahydroisoquinoline have been synthesized. Their cytotoxic activities and effects in reversing multidrug resistance have been evaluated. The results suggested that compounds 7d, 7f, and 7l had anticancer effects, as well as multidrug resistance reversal effects.Figure optionsDownload full-size imageDownload as PowerPoint slide
